PALVELLA THERAPEUTICS, INC.

PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583648

Price chart

Open-market purchases and sales by PVLA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 18, 20264:05 PM ETSep 16, 2026Goin KathleenChief Operating OfficerSSaleCommon Stock−4.3K$152.2368−$654.92K0−100.0%SEC10b5-1
Sep 15, 20269:15 PM ETSep 11 – Sep 15, 2026JENKINS GEORGE MDirectorSSaleCommon Stock−27.5K$151.5326−$4.17M160.12K−14.7%SEC10b5-1
Sep 4, 20264:05 PM ETSep 2, 2026KIRITSY CHRISTOPHER PDirectorSSaleCommon Stock−313$157.00−$49.14K250−55.6%SEC
Aug 20, 20264:05 PM ETAug 19, 2026Goin KathleenChief Operating OfficerSSaleCommon Stock−4.3K$152.2062−$654.79K0−100.0%SEC10b5-1
Jul 17, 20264:05 PM ETJul 15, 2026Goin KathleenChief Operating OfficerSSaleCommon Stock−4.3K$149.2774−$642.19K0−100.0%SEC10b5-1

The largest institutional positions in PVLA at the end of Q2 2026.

Institutions holding PVLA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
SUVRETTA CAPITAL MANAGEMENT, LLC1,135,406$173.51M3.65%−18,090−1.6%Reduced
JENNISON ASSOCIATES LLC960,619$146.8M0.09%+320,008+50.0%Added
BlackRock, Inc.918,357$140.34M0.00%+231,504+33.7%Added
Frazier Life Sciences Management, L.P.882,400$134.85M2.94%00.0%Unchanged
First Light Asset Management, LLC771,901$117.96M7.17%−208,857−21.3%Reduced